These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 17086361)

  • 1. Reduction of invasive potential in K-ras-transformed thyroid cells by restoring of TGF-beta pathway.
    Nicolussi A; D'Inzeo S; Gismondi A; Coppa A
    Clin Exp Metastasis; 2006; 23(5-6):237-48. PubMed ID: 17086361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of transforming growth factor beta-type II receptor reduces tumorigenicity and metastastic potential of K-ras-transformed thyroid cells.
    Turco A; Coppa A; Aloe S; Baccheschi G; Morrone S; Zupi G; Colletta G
    Int J Cancer; 1999 Jan; 80(1):85-91. PubMed ID: 9935236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Restored expression of transforming growth factor beta type II receptor in k-ras-transformed thyroid cells, TGF beta-resistant, reverts their malignant phenotype.
    Coppa A; Mincione G; Lazzereschi D; Ranieri A; Turco A; Lucignano B; Scarpa S; Ragano-Caracciolo M; Colletta G
    J Cell Physiol; 1997 Aug; 172(2):200-8. PubMed ID: 9258341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of extracellular signal-regulated kinase by TGF-beta1 via TbetaRII and Smad7 dependent mechanisms in human bronchial epithelial BEP2D cells.
    Huo YY; Hu YC; He XR; Wang Y; Song BQ; Zhou PK; Zhu MX; Li G; Wu DC
    Cell Biol Toxicol; 2007 Mar; 23(2):113-28. PubMed ID: 17096210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transforming growth factor-beta1 promotes invasiveness after cellular transformation with activated Ras in intestinal epithelial cells.
    Fujimoto K; Sheng H; Shao J; Beauchamp RD
    Exp Cell Res; 2001 Jun; 266(2):239-49. PubMed ID: 11399052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of responsiveness to TGF-beta1 in a thyroid carcinoma cell line with functional type I and type II TGF-beta receptors and Smad proteins, suggests a novel mechanism for TGF-beta insensitivity in carcinoma cells.
    Heldin NE; Bergström D; Hermansson A; Bergenstråhle A; Nakao A; Westermark B; ten Dijke P
    Mol Cell Endocrinol; 1999 Jul; 153(1-2):79-90. PubMed ID: 10459856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Restoration of transforming growth factor beta signaling pathway in human prostate cancer cells suppresses tumorigenicity via induction of caspase-1-mediated apoptosis.
    Guo Y; Kyprianou N
    Cancer Res; 1999 Mar; 59(6):1366-71. PubMed ID: 10096572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of TGF-β1/Smad3 Signaling in Carbon Tetrachloride-Induced Acute Liver Injury in Mice.
    Niu L; Cui X; Qi Y; Xie D; Wu Q; Chen X; Ge J; Liu Z
    PLoS One; 2016; 11(5):e0156090. PubMed ID: 27224286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transforming growth factor beta1 receptor II is downregulated by E1A in adenovirus-infected cells.
    Tarakanova VL; Wold WS
    J Virol; 2003 Sep; 77(17):9324-36. PubMed ID: 12915548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Restoration of transforming growth factor-beta type II receptor reduces tumorigenicity in the human adrenocortical carcinoma SW-13 cell line.
    Yamamoto N; Imai J; Watanabe M; Hiroi N; Sugano S; Yoshino G
    Horm Metab Res; 2006 Mar; 38(3):159-66. PubMed ID: 16673206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TGF-beta receptor 2 downregulation in tumour-associated stroma worsens prognosis and high-grade tumours show more tumour-associated macrophages and lower TGF-beta1 expression in colon carcinoma: a retrospective study.
    Bacman D; Merkel S; Croner R; Papadopoulos T; Brueckl W; Dimmler A
    BMC Cancer; 2007 Aug; 7():156. PubMed ID: 17692120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting endogenous transforming growth factor beta receptor signaling in SMAD4-deficient human pancreatic carcinoma cells inhibits their invasive phenotype1.
    Subramanian G; Schwarz RE; Higgins L; McEnroe G; Chakravarty S; Dugar S; Reiss M
    Cancer Res; 2004 Aug; 64(15):5200-11. PubMed ID: 15289325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Restoration of TGF-beta signalling reduces tumorigenicity in human lung cancer cells.
    Anumanthan G; Halder SK; Osada H; Takahashi T; Massion PP; Carbone DP; Datta PK
    Br J Cancer; 2005 Nov; 93(10):1157-67. PubMed ID: 16251876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The expression dynamics of transforming growth factor-β/Smad signaling in the liver fibrosis experimentally caused by Clonorchis sinensis.
    Yan C; Wang L; Li B; Zhang BB; Zhang B; Wang YH; Li XY; Chen JX; Tang RX; Zheng KY
    Parasit Vectors; 2015 Feb; 8():70. PubMed ID: 25649869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Albumin endocytosis in endothelial cells induces TGF-beta receptor II signaling.
    Siddiqui SS; Siddiqui ZK; Malik AB
    Am J Physiol Lung Cell Mol Physiol; 2004 May; 286(5):L1016-26. PubMed ID: 14729511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutual regulation of TGF-β1, TβRII and ErbB receptors expression in human thyroid carcinomas.
    Mincione G; Tarantelli C; Vianale G; Di Marcantonio MC; Cotellese R; Francomano F; Di Nicola M; Costantini E; Cichella A; Muraro R
    Exp Cell Res; 2014 Sep; 327(1):24-36. PubMed ID: 24973511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diverse roles of TGF-β receptor II in renal fibrosis and inflammation in vivo and in vitro.
    Meng XM; Huang XR; Xiao J; Chen HY; Zhong X; Chung AC; Lan HY
    J Pathol; 2012 Jun; 227(2):175-88. PubMed ID: 22190171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinctive mechanism for sustained TGF-β signaling and growth inhibition: MEK1 activation-dependent stabilization of type II TGF-β receptors.
    Chen G; Ghosh P; Longo DL
    Mol Cancer Res; 2011 Jan; 9(1):78-89. PubMed ID: 21131601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transforming growth factor-β (TGF-β) signaling in healthy human fetal skin: a descriptive study.
    Walraven M; Beelen RH; Ulrich MM
    J Dermatol Sci; 2015 May; 78(2):117-24. PubMed ID: 25795202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dasatinib blocks transcriptional and promigratory responses to transforming growth factor-beta in pancreatic adenocarcinoma cells through inhibition of Smad signalling: implications for in vivo mode of action.
    Bartscht T; Rosien B; Rades D; Kaufmann R; Biersack H; Lehnert H; Gieseler F; Ungefroren H
    Mol Cancer; 2015 Nov; 14():199. PubMed ID: 26588899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.